Theraflu ExtraGRIP

Quick links to important sections

Theraflu ExtraGRIP

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Theraflu ExtraGRIP

Property Description
Active ingredients Acetaminophen, Pheniramine Maleate, Phenylephrine Hydrochloride
Form Powder for oral solution (sachet/granules)
Pharmacological class Combination analgesic, antihistamine, and nasal decongestant
Common use Symptomatic relief of cold and flu discomforts
Origin Synthetic

Theraflu ExtraGRIP is a synthetic, multi-ingredient pharmaceutical product classified as an over-the-counter (OTC) combination preparation formulated for the symptomatic relief of common cold and influenza discomforts. Its identity is defined by the pharmacological synergy achieved between its three distinct active components, delivered as a hot drink powder—a distinct feature intended for soothing consumption.


What is the Combination and Pharmacological Class of Theraflu ExtraGRIP?

Theraflu ExtraGRIP blends an analgesic-antipyretic, an H1-antihistamine, and a nasal decongestant. This grouping is recognized for providing simultaneous management of multiple non-specific symptoms associated with upper respiratory viral infections. The Acetaminophen is included to reduce fever and pain; the Pheniramine Maleate helps manage allergy-like symptoms; and the Phenylephrine Hydrochloride is present to address nasal swelling. This formulation strategy is an approach used in comprehensive multi-symptom cold care.


What Active Ingredients and Form Define Theraflu ExtraGRIP?

The medicine's composition includes Acetaminophen (Paracetamol), Pheniramine Maleate, and Phenylephrine Hydrochloride. Acetaminophen is recognized as a standard for fever reduction. The unique presentation as a powder for oral solution packaged in sachets and prepared as a warm beverage is a key differentiator, focusing on oral administration that is often perceived as comforting when managing severe cold and flu symptoms.


What is the General Symptomatic Purpose of Theraflu ExtraGRIP?

The general purpose is to provide integrated multi-symptom relief, aiming to ease the patient's discomfort from symptoms such as a severe headache, persistent body aches, or a congested nose. The systemic action of its components helps to manage the elevated temperature and nasal obstruction that frequently accompany influenza. This product is positioned for individuals seeking a comprehensive symptomatic purpose—using one preparation to address several aspects of illness concurrently.

Regulatory References

  1. NIH Acetaminophen Fact Sheet

What side effects are possible with Theraflu ExtraGRIP?

Possible Side Effects and Safety Information

The safety profile of this medicine, which contains paracetamol, pheniramine, and phenylephrine, is primarily structured around the inherent risks of its active ingredients and necessary precautions.

Category Documented Adverse Reactions (Common)
Nervous System Dizziness, drowsiness, mild headache, insomnia, or feeling restless/excited (particularly in children).
Gastrointestinal Nausea, upset stomach, or dry mouth/throat.
Cardiovascular Nervousness, increased blood pressure, or fast/uneven heart rate (palpitations) due to the sympathomimetic component.

Serious Adverse Reactions and Key Warnings

Liver Toxicity: A major safety warning involves the risk of severe liver damage from paracetamol overdose. This risk is compounded by exceeding the maximum daily dose (typically 4,000 mg of paracetamol for adults) or concurrent use with other products containing paracetamol.

Allergic Reactions: Severe hypersensitivity reactions are rare but require immediate medical attention. Symptoms may include hives, swelling of the face, lips, tongue, or throat (angioedema), and difficulty breathing. Additionally, paracetamol has been associated with severe, rare skin reactions (e.g., Stevens-Johnson syndrome).

Contraindications and Restrictions:

  • Drug Interactions: The medicine is strictly contraindicated for use with or within 14 days of stopping a Monoamine Oxidase Inhibitor (MAOI). Concomitant use with other sympathomimetics, tricyclic antidepressants, or certain heart medications requires caution.
  • Specific Populations: Use is contraindicated in children under 12 years of age, during pregnancy, and while breastfeeding. Caution is necessary for patients with liver disease, severe high blood pressure, glaucoma, hyperthyroidism, or an enlarged prostate.
  • Impairment: Due to the risk of marked drowsiness and impaired thinking, caution is advised when driving or operating machinery.

The duration of use is generally limited; if fever worsens or lasts more than three days, or if new symptoms occur, medical advice should be sought.

Overdose and Emergency Response

Overdose and when to seek help

Overdose involving this combination product is classified as a serious medical event that requires immediate professional intervention, as documented by regulatory authorities. The clinical manifestations and risk profile are derived from the toxicological properties of its three active components.

The principal, life-threatening risk is associated with the Acetaminophen component, which may lead to severe liver damage and potentially fatal hepatic failure. Initial documented symptoms often include nausea, vomiting, abdominal pain, and sweating. Later signs can progress to jaundice or severe upper stomach pain. Individuals with pre-existing liver disease or those who consume three or more alcoholic drinks daily are officially identified as having an increased risk for this severe outcome.

Over-exposure to the decongestant and antihistamine components may cause acute central nervous system (CNS) and cardiovascular effects, including confusion, seizures, hallucinations, or hypertensive crisis and arrhythmias.

Required Emergency Action

The official labeling requires all individuals to seek emergency medical attention or contact a Poison Control Center right away upon any suspicion of overdose, even if no symptoms are noticeable. Prompt medical assessment is critical for initiating specific time-sensitive management protocols, including the administration of the antidote, N-acetylcysteine, and continuous monitoring of hepatic and renal function.

Therapeutic Uses of Theraflu ExtraGRIP

What Theraflu ExtraGRIP Treats: Main Uses and Benefits

Multi-ingredient preparations are relevant for easing the cluster of symptoms associated with the common cold and flu. Theraflu ExtraGRIP may be relevant across domains where additional symptomatic support is needed, primarily to help manage episodes characterized by acute or disruptive manifestations.

Relief of Systemic Pain and Acute Febrile Discomfort

Theraflu ExtraGRIP may be relevant in contexts involving heightened systemic burden, primarily to help ease generalized body aches, persistent headache, and elevated body temperature (fever). It provides supportive relief that contributes to easing the overall symptom burden of pain and fever during acute, non-specific febrile illness.

Management of Nasal and Sinus Symptom Clusters

The medication is commonly used for managing symptom clusters that may become intense or disruptive due to upper respiratory irritation. It is generally used to help with acute nasal congestion, excessive runny nose (rhinorrhea), and frequent sneezing, supporting the patient during difficult episodes by easing distress and supporting general well-being during symptomatic phases.

Comprehensive Support for Multi-Symptom Episodes

Applicable within clinical settings that involve acute or disruptive symptom patterns, this combination is used for conditions presenting with the characteristic manifestations of the common cold and influenza. The preparation may be part of symptomatic management, as it helps address systemic pain, fever, and nasal issues concurrently, supporting patients during periods of heightened discomfort by easing the impact of symptoms on routine activities.

Quick Fact: Used to help manage Fever, Body Aches, and Nasal Congestion

Regulatory References

  1. NIH MedlinePlus overview on Cold and Cough Medicines

Eligibility and Restrictions for Use

This information details the population eligibility and non-eligibility for Theraflu ExtraGRIP strictly according to regulatory labeling from authoritative sources.

Contraindications and Age Exclusions

Theraflu ExtraGRIP is absolutely contraindicated for certain groups due to the risk of serious adverse effects:

  • Children under 12 years of age must not use this product.
  • Individuals with a known allergy or hypersensitivity to acetaminophen or any other ingredient in the formulation.
  • Patients who are currently taking or have stopped taking a Monoamine Oxidase Inhibitor (MAOI) within the last 14 days.
  • Individuals taking any other drug containing acetaminophen (prescription or nonprescription).

Conditional Use and Comorbidities

Use of this medicine is restricted or requires mandatory consultation with a healthcare professional if the patient has certain pre-existing conditions. A doctor must be consulted prior to use if the patient has:

  • Liver disease
  • Heart disease, high blood pressure, thyroid disease, or diabetes
  • Glaucoma or trouble urinating due to an enlarged prostate gland
  • A breathing problem such as emphysema or chronic bronchitis.

Pregnancy and Lactation Status

If pregnant or breast-feeding, the regulatory label requires the user to ask a health professional before use, establishing a conditional eligibility status for these populations.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the documented interactions for Theraflu ExtraGRIP, based on the product's active ingredients (typically Acetaminophen, Dextromethorphan, Phenylephrine, and/or an Antihistamine). All interactions are based on official regulatory labeling.


Contraindicated Combinations

Monoamine Oxidase Inhibitors (MAOIs): Use is strictly contraindicated with MAOIs or within two weeks of stopping MAOI therapy. This is due to the risk of severe hypertensive crisis and Serotonin Syndrome.

Other Acetaminophen Products: This medication must not be taken with any other product containing Acetaminophen (prescription or nonprescription) due to the risk of severe liver damage.

Pharmacodynamic and Alcohol Interactions

Interacting Substance/Class Potential Effect (Official Labeling)
Alcoholic Drinks Avoid use; increases the risk of liver damage and heightens sedation from the Antihistamine.
CNS Depressants (Sedatives, Tranquilizers, other Antihistamines) Increased drowsiness and Central Nervous System depression.
Warfarin (Oral Anticoagulant) May alter the anticoagulant effect (e.g., increased bleeding risk); consultation with a healthcare provider is required.

Pharmacokinetic Context

The Acetaminophen component's metabolism is influenced by alcohol, increasing the formation of a toxic metabolite. The MAOI contraindication also relates to metabolic pathways affecting Dextromethorphan and Phenylephrine.

Mechanism of Action

The pharmacological components of Theraflu ExtraGRIP operate on distinct biochemical pathways and elicit effects by acting on multiple physiological targets. The mechanism involves the simultaneous modulation of three distinct systems: pain/fever signaling, vascular regulation, and the medullary cough reflex.

Acetaminophen modulates the central prostaglandin synthesis pathway, resulting in the inhibition of pyrogenic and nociceptive signaling. Phenylephrine functions as a selective alpha1-adrenergic receptor agonist, leading to vasoconstriction in the nasal and sinus vasculature. Dextromethorphan, a sigma-1 receptor agonist and a noncompetitive NMDA receptor antagonist in the medulla, alters the afferent and efferent components of the cough reflex arc. The resulting physiological responses are sustained due to the compounds' pharmacokinetic profiles.

Dosage and Administration Information

How to use Theraflu ExtraGRIP: Administration Guidelines

This section outlines the dosage and administration instructions for Theraflu ExtraGRIP.

Dosage and Administration Protocol

The product is administered via the oral route as a hot liquid solution, reconstituted from a powder packet.

Administration Rule Instruction
Standard Single Dose The contents of one packet
Dosing Frequency Take every 4 hours as symptoms persist
Maximum Daily Dose Do not exceed 5 or 6 packets (varies by specific formulation) in a 24-hour period
Duration Constraint Discontinue use if symptoms worsen or last more than 7 days, or if fever persists for more than 3 days

Preparation and Procedural Steps

  1. Dissolve the entire contents of one packet into 8 oz. of hot water.
  2. Stir the solution completely.
  3. Sip while hot, and consume the entire drink within 10 to 15 minutes.
  4. For microwave preparation, add the powder to 8 oz. of cool water and stir before and after heating; do not overheat.

Age-Specific Use

  • Adults and Children 12 years of age and over: Use one packet per dose, adhering to the standard frequency and maximum daily limit.
  • Children under 12 years of age: This product is not authorized for use in this age group.

Recent Clinical Evidence

Research evidence / Overview of Studies for Theraflu ExtraGRIP

Evidence for the Multi-Symptom Relief of Cold and Flu

The combination of ingredients in this product was studied in research exploring how symptoms change over time related to cold and flu. Short-term Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews form the primary research structure, which was applied in studies examining patient-reported experiences of conditions characterized by fluctuating or episodic manifestations. These studies monitored outcomes related to systemic or functional imbalance by measuring how the patient's overall symptom severity evolved during the acute phase of illness. This evidence contributes to the broader evidence landscape and is generally assigned a Moderate level of certainty in formal regulatory reviews.

Research on Pain and Fever Reduction (Acetaminophen Component)

The component was studied for its effects on physical discomfort associated with pain and fever was evaluated in an established body of evidence that was evaluated in research exploring temporary physiological imbalance. Data show patterns related to changes in fever and pain scores following administration. This evidence contributes to the broader evidence landscape and is assigned a High level of certainty by regulatory bodies. While the component's action is well characterized, regulatory reviews emphasize that the potential for high-dose safety considerations was associated with Acetaminophen when used across multiple products.

Study Structure for Nasal and Allergy Symptoms

The research base for the other two components—the antihistamine (Pheniramine) and the oral decongestant (Phenylephrine)—was studied for its effects on upper respiratory irritation. Studies have observed patterns in outcomes related to inflammatory or irritative states such as runny nose and sneezing scores. However, the evidence for the oral decongestant component (Phenylephrine) relieving nasal congestion was observed in some studies but findings were mixed in subsequent regulatory committee reviews, leading to a classification where the evidence certainty remains Low for this specific action. The antihistamine component was associated with patterns related to sedation or drowsiness, which is a factor documented in the research base.

Key Studies & References Summary Safety Review - Phenylephrine and acetaminophen - Drug-drug interaction (Health Canada)

Frequently Asked Questions (FAQ)

Common questions about Theraflu ExtraGRIP (FAQ)


Q: What kind of cough does Theraflu ExtraGRIP treat?

According to official product labeling, this medicine is indicated for the temporary relief of cough due to minor throat and bronchial irritation. If the cough occurs with excessive phlegm (mucus) or is chronic (for example, a smoker's cough), consultation with a health professional is advised before use.


Q: How long do the effects of Theraflu ExtraGRIP usually last?

Regulatory documents indicate that the dosing frequency for this medicine is typically every 4 hours as symptoms persist. This frequency reflects the regulatory recommendation for continued use.


Q: Can I take Theraflu ExtraGRIP if I'm only congested but don't have a cough?

The product is officially indicated for the temporary relief of a combination of cold and flu symptoms. The active ingredients are included to address multiple issues, including nasal and sinus congestion. The drug label lists the multiple symptoms the product is intended to manage.


Q: Why does Theraflu ExtraGRIP make some people feel drowsy?

Official labeling notes that side effects can include drowsiness or sedation. This effect is associated with the Pheniramine Maleate component, which is an antihistamine. Combining this product with other Central Nervous System depressants, like alcohol or sedatives, can heighten the feeling of sleepiness.


Q: Can Theraflu ExtraGRIP interact with blood pressure medication?

Due to the presence of Phenylephrine (a nasal decongestant), official warnings advise consultation with a health professional if the patient has high blood pressure or heart disease. While specific interactions with all blood pressure medications are not detailed on the general OTC label, certain drug classes, such as MAOIs, are strictly contraindicated.


Q: Is it safe to take Theraflu ExtraGRIP with common allergy pills?

Regulatory information advises caution against taking this medicine with other Central Nervous System (CNS) depressants, including other antihistamines. Many common allergy pills contain antihistamines, and combining them with the Pheniramine in Theraflu can lead to increased drowsiness and CNS depression.


Q: Why do official sources limit the use of this medicine to a few days?

Regulatory agencies place a time constraint on use, advising users to discontinue the product if symptoms persist for more than 7 days. This is primarily a safety precaution related to the Acetaminophen component, which carries a warning about the risk of severe liver damage when taken in high doses or over a long duration.


Q: What happens if I take Theraflu ExtraGRIP too close to taking a pain reliever like Advil?

The most stringent regulatory warning is that this medication must not be taken with any other product containing Acetaminophen (paracetamol), as this dramatically increases the risk of severe liver damage. The product label does not specifically address interactions with non-acetaminophen pain relievers like Ibuprofen (Advil).


Q: Can older adults use Theraflu ExtraGRIP?

This product is authorized for use by adults and children 12 years of age and over. However, the official label requires consultation with a doctor before use if the patient has conditions that are more common in older adults, such as heart disease, high blood pressure, glaucoma, or trouble urinating.


Q: Does Theraflu ExtraGRIP contain aspirin?

No. The official labeling lists the active ingredients as Acetaminophen (pain reliever/fever reducer), Pheniramine Maleate (antihistamine), and Phenylephrine Hydrochloride (nasal decongestant). Aspirin is not one of the active ingredients.


Q: Is Theraflu ExtraGRIP an antibiotic?

No. Official product information classifies Theraflu ExtraGRIP as a Human Over-the-Counter (OTC) Drug. It is a combination product containing a pain reliever, a fever reducer, an antihistamine, and a nasal decongestant, intended only for the temporary relief of symptoms.


Q: Can I take Theraflu ExtraGRIP if I am sensitive to pseudoephedrine?

The nasal decongestant component in this specific product is Phenylephrine HCl, not Pseudoephedrine. Official product information does not address the question of cross-sensitivity between these ingredients.


Q: What is the purpose of the antihistamine component in the drug?

The antihistamine component, Pheniramine Maleate, is included in the formulation to help manage allergy-like symptoms associated with cold or flu. This includes symptoms such as a runny nose and sneezing.


Q: Does Theraflu ExtraGRIP help with sinus pressure?

The product is formulated to relieve symptoms including nasal and sinus congestion. The decongestant component, Phenylephrine, is intended to relieve congestion, which is often the cause of uncomfortable sinus pressure.


Q: Can I take Theraflu ExtraGRIP if I am on an antidepressant?

Strict contraindications exist for use with Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of stopping them. Caution is also advised regarding other drug classes, such as tricyclic antidepressants. The official label advises a consultation with a health professional regarding the use of this medicine with any other prescribed antidepressant.


Q: What is the difference between Theraflu ExtraGRIP and the Nighttime formula?

Regulatory documents indicate that different Theraflu formulations contain varying active ingredients to achieve specific effects. For instance, a nighttime formula often contains an ingredient to aid sleep, like an antihistamine that causes drowsiness (such as Diphenhydramine), which may differ from the antihistamine used in daytime or 'ExtraGRIP' formulations.


Q: What are the inactive ingredients in Theraflu ExtraGRIP?

Official drug labels list all ingredients. The inactive ingredients, which do not have a therapeutic effect, may include various components such as sucrose, citric acid, maltodextrin, aspartame, and specific flavors and colorants used to make the hot liquid solution.


Q: Are there any specific foods I should avoid when using this medicine?

Official labeling contains a warning for individuals with Phenylketonurics (PKU) because the product often contains phenylalanine (an artificial sweetener). Beyond this specific warning, the label does not generally list specific foods that must be avoided, but consumption of alcohol is strongly advised against due to safety risks.


Q: Can I take a single dose and then stop if my symptoms go away?

The directions for use state to take the dose every 4 hours. The directions advise that dosing should continue while symptoms persist.

How should Theraflu ExtraGRIP be stored and disposed of?

How to Store and Dispose of Theraflu ExtraGRIP

The storage and disposal of Theraflu ExtraGRIP powder must adhere strictly to official regulatory guidelines to maintain product quality and ensure safety.


Official Storage Requirements

Condition Regulatory Requirement
Temperature Store at controlled room temperature, defined as 20°–25°C (68°–77°F).
Protection The product must be protected from excessive heat and moisture.
Packaging Keep the medicine in its original container and do not use if the packet is torn or broken.
Child Safety Store the medicine strictly out of the sight and reach of children.

Disposal Instructions

When the product is expired or no longer needed, it must be discarded properly.

Regulatory documents advise consulting a pharmacist or local waste disposal company for proper handling. To protect the environment, do not flush medications down the toilet or pour them into a drain unless specifically authorized.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Theraflu ExtraGRIP found in:

A-Z Index: